nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—peripheral nervous system neoplasm	0.564	1	CbGaD
Fidaxomicin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0835	0.239	CbGbCtD
Fidaxomicin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0835	0.239	CbGbCtD
Fidaxomicin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0579	0.166	CbGbCtD
Fidaxomicin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0357	0.102	CbGbCtD
Fidaxomicin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0333	0.0953	CbGbCtD
Fidaxomicin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0327	0.0937	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0223	0.0639	CbGbCtD
Fidaxomicin—Metabolic acidosis—Etoposide—peripheral nervous system neoplasm	0.00198	0.0227	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Topotecan—peripheral nervous system neoplasm	0.00195	0.0225	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Vincristine—peripheral nervous system neoplasm	0.00142	0.0163	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000959	0.011	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000959	0.011	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.000853	0.0098	CcSEcCtD
Fidaxomicin—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.000835	0.0096	CcSEcCtD
Fidaxomicin—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.000835	0.0096	CcSEcCtD
Fidaxomicin—Dysphagia—Isotretinoin—peripheral nervous system neoplasm	0.000829	0.00953	CcSEcCtD
Fidaxomicin—Dysphagia—Tretinoin—peripheral nervous system neoplasm	0.000829	0.00953	CcSEcCtD
Fidaxomicin—Neutropenia—Topotecan—peripheral nervous system neoplasm	0.000782	0.00898	CcSEcCtD
Fidaxomicin—Neutropenia—Tretinoin—peripheral nervous system neoplasm	0.000775	0.00891	CcSEcCtD
Fidaxomicin—Neutropenia—Isotretinoin—peripheral nervous system neoplasm	0.000775	0.00891	CcSEcCtD
Fidaxomicin—Neutropenia—Melphalan—peripheral nervous system neoplasm	0.000765	0.0088	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000727	0.00836	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Topotecan—peripheral nervous system neoplasm	0.000705	0.0081	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Melphalan—peripheral nervous system neoplasm	0.00069	0.00793	CcSEcCtD
Fidaxomicin—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.000678	0.00779	CcSEcCtD
Fidaxomicin—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.000634	0.00728	CcSEcCtD
Fidaxomicin—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.000633	0.00727	CcSEcCtD
Fidaxomicin—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.00722	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00062	0.00712	CcSEcCtD
Fidaxomicin—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000604	0.00695	CcSEcCtD
Fidaxomicin—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000592	0.0068	CcSEcCtD
Fidaxomicin—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.000588	0.00675	CcSEcCtD
Fidaxomicin—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.000582	0.00669	CcSEcCtD
Fidaxomicin—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.000578	0.00664	CcSEcCtD
Fidaxomicin—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.000578	0.00664	CcSEcCtD
Fidaxomicin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.000569	0.00654	CcSEcCtD
Fidaxomicin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.000569	0.00654	CcSEcCtD
Fidaxomicin—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.000566	0.00651	CcSEcCtD
Fidaxomicin—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000538	0.00619	CcSEcCtD
Fidaxomicin—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000534	0.00614	CcSEcCtD
Fidaxomicin—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000534	0.00614	CcSEcCtD
Fidaxomicin—Angioedema—Topotecan—peripheral nervous system neoplasm	0.000532	0.00612	CcSEcCtD
Fidaxomicin—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000527	0.00606	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.000501	0.00575	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000492	0.00566	CcSEcCtD
Fidaxomicin—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.000491	0.00564	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000489	0.00562	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000489	0.00562	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000482	0.00554	CcSEcCtD
Fidaxomicin—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000481	0.00553	CcSEcCtD
Fidaxomicin—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000481	0.00553	CcSEcCtD
Fidaxomicin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000466	0.00536	CcSEcCtD
Fidaxomicin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000462	0.00532	CcSEcCtD
Fidaxomicin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000462	0.00532	CcSEcCtD
Fidaxomicin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000462	0.00531	CcSEcCtD
Fidaxomicin—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.000459	0.00527	CcSEcCtD
Fidaxomicin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000458	0.00526	CcSEcCtD
Fidaxomicin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000458	0.00526	CcSEcCtD
Fidaxomicin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000452	0.0052	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000452	0.00519	CcSEcCtD
Fidaxomicin—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000438	0.00503	CcSEcCtD
Fidaxomicin—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000437	0.00502	CcSEcCtD
Fidaxomicin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.00496	CcSEcCtD
Fidaxomicin—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000424	0.00487	CcSEcCtD
Fidaxomicin—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00042	0.00483	CcSEcCtD
Fidaxomicin—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00042	0.00483	CcSEcCtD
Fidaxomicin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000418	0.00481	CcSEcCtD
Fidaxomicin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000415	0.00477	CcSEcCtD
Fidaxomicin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000415	0.00477	CcSEcCtD
Fidaxomicin—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000415	0.00477	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000414	0.00475	CcSEcCtD
Fidaxomicin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000413	0.00475	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00041	0.00472	CcSEcCtD
Fidaxomicin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00041	0.00471	CcSEcCtD
Fidaxomicin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.00471	CcSEcCtD
Fidaxomicin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00041	0.00471	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000407	0.00468	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000407	0.00468	CcSEcCtD
Fidaxomicin—Constipation—Topotecan—peripheral nervous system neoplasm	0.000407	0.00467	CcSEcCtD
Fidaxomicin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00465	CcSEcCtD
Fidaxomicin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000405	0.00465	CcSEcCtD
Fidaxomicin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00464	CcSEcCtD
Fidaxomicin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00464	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000402	0.00462	CcSEcCtD
Fidaxomicin—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00039	0.00448	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000389	0.00447	CcSEcCtD
Fidaxomicin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00445	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00443	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00443	CcSEcCtD
Fidaxomicin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000376	0.00432	CcSEcCtD
Fidaxomicin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000373	0.00429	CcSEcCtD
Fidaxomicin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000373	0.00428	CcSEcCtD
Fidaxomicin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000373	0.00428	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00426	CcSEcCtD
Fidaxomicin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000368	0.00423	CcSEcCtD
Fidaxomicin—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00419	CcSEcCtD
Fidaxomicin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000355	0.00408	CcSEcCtD
Fidaxomicin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00403	CcSEcCtD
Fidaxomicin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00035	0.00403	CcSEcCtD
Fidaxomicin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000347	0.00399	CcSEcCtD
Fidaxomicin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000347	0.00399	CcSEcCtD
Fidaxomicin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00399	CcSEcCtD
Fidaxomicin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000345	0.00396	CcSEcCtD
Fidaxomicin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000343	0.00394	CcSEcCtD
Fidaxomicin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000338	0.00388	CcSEcCtD
Fidaxomicin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000336	0.00387	CcSEcCtD
Fidaxomicin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.00385	CcSEcCtD
Fidaxomicin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000335	0.00385	CcSEcCtD
Fidaxomicin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000334	0.00383	CcSEcCtD
Fidaxomicin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000334	0.00383	CcSEcCtD
Fidaxomicin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000329	0.00379	CcSEcCtD
Fidaxomicin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00366	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000318	0.00366	CcSEcCtD
Fidaxomicin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000316	0.00363	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000315	0.00363	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.00362	CcSEcCtD
Fidaxomicin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00362	CcSEcCtD
Fidaxomicin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000314	0.00361	CcSEcCtD
Fidaxomicin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00358	CcSEcCtD
Fidaxomicin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00358	CcSEcCtD
Fidaxomicin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00357	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00355	CcSEcCtD
Fidaxomicin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00351	CcSEcCtD
Fidaxomicin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000305	0.0035	CcSEcCtD
Fidaxomicin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000302	0.00347	CcSEcCtD
Fidaxomicin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0003	0.00345	CcSEcCtD
Fidaxomicin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0003	0.00345	CcSEcCtD
Fidaxomicin—Rash—Topotecan—peripheral nervous system neoplasm	0.0003	0.00345	CcSEcCtD
Fidaxomicin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000299	0.00344	CcSEcCtD
Fidaxomicin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000299	0.00344	CcSEcCtD
Fidaxomicin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00343	CcSEcCtD
Fidaxomicin—Headache—Topotecan—peripheral nervous system neoplasm	0.000298	0.00342	CcSEcCtD
Fidaxomicin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000297	0.00342	CcSEcCtD
Fidaxomicin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000297	0.00342	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000297	0.00342	CcSEcCtD
Fidaxomicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000297	0.00341	CcSEcCtD
Fidaxomicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000297	0.00341	CcSEcCtD
Fidaxomicin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000296	0.0034	CcSEcCtD
Fidaxomicin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000296	0.0034	CcSEcCtD
Fidaxomicin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000295	0.0034	CcSEcCtD
Fidaxomicin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000295	0.0034	CcSEcCtD
Fidaxomicin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000294	0.00338	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.00338	CcSEcCtD
Fidaxomicin—Rash—Melphalan—peripheral nervous system neoplasm	0.000293	0.00337	CcSEcCtD
Fidaxomicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000293	0.00337	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00336	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000289	0.00332	CcSEcCtD
Fidaxomicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000284	0.00326	CcSEcCtD
Fidaxomicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00325	CcSEcCtD
Fidaxomicin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000282	0.00325	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000282	0.00324	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00323	CcSEcCtD
Fidaxomicin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00028	0.00322	CcSEcCtD
Fidaxomicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00028	0.00322	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00318	CcSEcCtD
Fidaxomicin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000276	0.00318	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00316	CcSEcCtD
Fidaxomicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000272	0.00313	CcSEcCtD
Fidaxomicin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00312	CcSEcCtD
Fidaxomicin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000271	0.00311	CcSEcCtD
Fidaxomicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00304	CcSEcCtD
Fidaxomicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00303	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00302	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00298	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.00296	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00294	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00292	CcSEcCtD
Fidaxomicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000254	0.00292	CcSEcCtD
Fidaxomicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.00291	CcSEcCtD
Fidaxomicin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000249	0.00286	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.00285	CcSEcCtD
Fidaxomicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000245	0.00282	CcSEcCtD
Fidaxomicin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000243	0.00279	CcSEcCtD
Fidaxomicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000243	0.00279	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000241	0.00277	CcSEcCtD
Fidaxomicin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000239	0.00274	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00273	CcSEcCtD
Fidaxomicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00272	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00267	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00264	CcSEcCtD
Fidaxomicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.00263	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000228	0.00262	CcSEcCtD
Fidaxomicin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000228	0.00262	CcSEcCtD
Fidaxomicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.00261	CcSEcCtD
Fidaxomicin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00259	CcSEcCtD
Fidaxomicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00259	CcSEcCtD
Fidaxomicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00258	CcSEcCtD
Fidaxomicin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00257	CcSEcCtD
Fidaxomicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000221	0.00253	CcSEcCtD
Fidaxomicin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000219	0.00252	CcSEcCtD
Fidaxomicin—Rash—Vincristine—peripheral nervous system neoplasm	0.000217	0.0025	CcSEcCtD
Fidaxomicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000217	0.00249	CcSEcCtD
Fidaxomicin—Headache—Vincristine—peripheral nervous system neoplasm	0.000216	0.00248	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00247	CcSEcCtD
Fidaxomicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00244	CcSEcCtD
Fidaxomicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000206	0.00236	CcSEcCtD
Fidaxomicin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000205	0.00235	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00229	CcSEcCtD
Fidaxomicin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000197	0.00227	CcSEcCtD
Fidaxomicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000194	0.00223	CcSEcCtD
Fidaxomicin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00221	CcSEcCtD
Fidaxomicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000192	0.0022	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000192	0.0022	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00217	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00216	CcSEcCtD
Fidaxomicin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000184	0.00212	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00211	CcSEcCtD
Fidaxomicin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000181	0.00208	CcSEcCtD
Fidaxomicin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000177	0.00204	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00204	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00204	CcSEcCtD
Fidaxomicin—Rash—Etoposide—peripheral nervous system neoplasm	0.000176	0.00202	CcSEcCtD
Fidaxomicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000176	0.00202	CcSEcCtD
Fidaxomicin—Headache—Etoposide—peripheral nervous system neoplasm	0.000175	0.00201	CcSEcCtD
Fidaxomicin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00201	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.002	CcSEcCtD
Fidaxomicin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000166	0.0019	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00188	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00186	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00183	CcSEcCtD
Fidaxomicin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00176	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00175	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00172	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.0017	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00163	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00162	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000139	0.0016	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00158	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00156	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00155	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00154	CcSEcCtD
Fidaxomicin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00148	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00147	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00146	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00145	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00144	CcSEcCtD
Fidaxomicin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00142	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00142	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00136	CcSEcCtD
Fidaxomicin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00132	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00131	CcSEcCtD
Fidaxomicin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00127	CcSEcCtD
Fidaxomicin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00123	CcSEcCtD
Fidaxomicin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00119	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00118	CcSEcCtD
Fidaxomicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.00114	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.00113	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.00113	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.00113	CcSEcCtD
Fidaxomicin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.0011	CcSEcCtD
Fidaxomicin—Nausea—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.00107	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.00106	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.00105	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.00105	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.00104	CcSEcCtD
Fidaxomicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000988	CcSEcCtD
